Yasuo Nakagishi

Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Masaki Shimizu, Yasuo Nakagishi, Natsumi Inoue et al. · Clinical Immunology · 2015 · 175 citations

Life Sciences, Immunology, Pathobiology +14

Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles

Masaki Shimizu, Yasuo Nakagishi, Akihiro Yachie · Cytokine · 2012 · 130 citations

Medicine, Immunology, Pathology +13

Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6

Masaki Shimizu, Yasuo Nakagishi, Kazuko Kasai et al. · Cytokine · 2012 · 129 citations

Medicine, Immunology, Pediatrics +14

Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome

Mao Mizuta, Masaki Shimizu, Natsumi Inoue et al. · Cytokine · 2019 · 53 citations

Life Sciences, Immunology, Molecular Medicine +16

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Masaki Shimizu, Mao Mizuta, Nami Okamoto et al. · Pediatric Rheumatology · 2020 · 47 citations · Full text

Medicine, Immunology, Pediatrics +16